Category Archives: Circulation, metabolism, nutrition

A Vaccine Against Chronic Inflammatory Diseases

By Léa Surugue | Published: 11 December 2019

In animals, a vaccine modifying the composition and function of the gut microbiota provides protection against the onset of chronic inflammatory bowel diseases and certain metabolic disorders, such as diabetes and obesity.

Also posted in Press releases, Immunology, inflammation, infectiology and microbiology | Comments closed

Metastasis: When Cancer Cells Hitch a Ride Through the Bloodstream

By Lea Roy | Published: 3 December 2019
Imagerie de billes fluorescentes sont filmées à très haute vitesse,

Circulating tumor cells use the blood and lymphatic networks to disseminate within the body, forming metastases distant from the primary tumor. Inserm researcher Jacky Goetz and his Tumor Biomechanics team at the Molecular ImmunoRheumatology laboratory (Inserm/Université de Strasbourg) have helped to show that the flow properties of these biological fluids have a huge influence on the risk of developing metastases.

Also posted in Cancer, Press releases | Tagged | Comments closed

Les risques de complication de l’obésité dépendraient avant tout de la composition du tissu adipeux

By Graziella Cara | Published: 19 November 2019

Se reposer uniquement sur la quantité de masse grasse semble constituer une approche trop réductrice pour prédire efficacement le risque de complications métaboliques et cardiovasculaires associées à l’obésité. L’équipe Inserm de Laurent Lagrost (Inserm UMR1231 “Lipides, nutrition, cancer”, Université de Bourgogne-Franche-Comté, Dijon) montre que, chez la souris, c’est la composition du tissu adipeux, et non sa quantité, qui est associée à l’espérance de vie.

Also posted in Press releases | Tagged | Comments closed

Type 1 diabetes : a research update from Inserm

By Graziella Cara | Published: 13 November 2019

From the discovery of insulin in 1921 to the first ever pancreas transplants in the late 1960s, the recent history of type 1 diabetes research has brought scientific and medical advances which have transformed patient prognosis and quality of life. Here at Inserm, eleven teams distributed among nine units contribute their own endeavors. Their work primarily involves the characterization of pancreatic cells and improving knowledge of the disease (risk factors, genetic susceptibility, pathophysiological mechanisms) and its complications. One of these teams, based in Lille, is exploring islet transplantation, a promising technique discussed in a new publication in Diabetes Care[1] and in an update in The Lancet[2]. Other very interesting avenues currently being explored include immunotherapy and the development of artificial pancreases.

Also posted in Press releases | Tagged | Comments closed

Atopic dermatitis: how allergens get on our nerves

By Léa Surugue | Published: 7 October 2019

Atopic dermatitis, or eczema, primarily affects infants and children, and manifests itself in hypersensitivity to allergens in the environment. A skin disease characterized by flare-ups, it is often treated with topical anti-inflammatories. A new study shows that immune cells and sensory neurons interact in the skin to form units that can detect allergens and trigger inflammation. A discovery that provides an insight into how atopic dermatitis works, and points the way to new therapeutic possibilities.

Also posted in Molecular and structural bases of living organisms, Press releases | Tagged | Comments closed

Elaboration et validation de l’iBox, le premier outil universel de prédiction du risque de perte de rein greffé basé sur l’intelligence artificielle.

By Graziella Cara | Published: 17 September 2019

Des équipes de deux centres majeurs de transplantation rénale de l’AP-HP (à l’hôpital Necker-Enfants malades et à l’hôpital Saint-Louis) et de l’Université de Paris, ont coordonné, au sein du « Centre d’expertise de la transplantation d’organe » de l’unité Inserm 970 dirigé par le Pr Alexandre Loupy, une étude internationale ayant permis d’élaborer et de valider iBox, le premier algorithme universel de prédiction du risque de perte de rein greffé.

Also posted in Press releases | Tagged | Comments closed

The natural lipids in buttermilk could contribute to reducing cardiovascular risk in vulnerable populations

By Graziella Cara | Published: 12 June 2019

Un consortium français vient de montrer que la consommation de certains lipides présents naturellement dans les produits laitiers (appelés « lipides polaires ») pourrait réduire le risque cardiovasculaire chez les femmes ménopausées et en surpoids.

Also posted in Press releases | Tagged | Comments closed

A New Atherosclerosis Marker on the Way

By Graziella Cara | Published: 6 June 2019

A team of researchers are proposing a new radioactive tracer to locate atheromatous plaques in arterial walls, which can cause cardiovascular events.

Also posted in Press releases | Tagged | Comments closed

Fertility and endometriosis: a research update from Inserm

By Graziella Cara | Published: 30 April 2019

Today, around 1 in 8 couples seek help because they are struggling to conceive. Infertility has therefore become a public health problem, and the scientific community is rallying in response.

Also posted in Cell biology, development and evolution, Press releases, Immunology, inflammation, infectiology and microbiology | Tagged | Comments closed

Artificial Intelligence Facilitates Chemical Toxicity Evaluation: the Case of Bisphenol S

By Graziella Cara | Published: 17 April 2019

A novel IT tool based on artificial intelligence methods has made it possible to identify the toxic effects of bisphenol S – a frequent substitute for bisphenol A in food containers.

Also posted in Press releases, Public health | Tagged | Comments closed
fermer
fermer
RSS Youtube